Loading clinical trials...
Loading clinical trials...
The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections
The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.
This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.
Age
1 - No limit years
Sex
ALL
Healthy Volunteers
Yes
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany
Start Date
January 1, 1995
Primary Completion Date
December 1, 2050
Completion Date
December 1, 2050
Last Updated
April 1, 2013
100,000
ESTIMATED participants
Antiinfectives
DRUG
Lead Sponsor
University Hospital of Cologne
NCT03375307
NCT03191149
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions